Aspire-Lakewood Holdings, Inc.

ASBPW ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › Balance Sheet
Annual Quarterly

Balance Sheet

Line Item Jun 2026 Mar 2026 Dec 2025 Sep 2025 Jun 2025 Mar 2025 Dec 2024 Sep 2024
Assets
Cash & Equivalents $12.2M $5.9M $1.0M $1.9M $206.2K $1.3M $3.6K $16.5K
Accounts Receivable — — — — — — — —
Inventory $288.5K $370.0K $253.2K $35.4K — — — —
Total Current Assets $13.5M $7.1M $1.3M $2.4M $989.4K $2.0M $148.0K $61.8K
Property, Plant & Equipment — — — — — — — —
Goodwill — — — — — — — —
Intangible Assets (Excl. Goodwill) — — — — — — — —
Total Assets $13.5M $7.1M $1.3M $2.4M $989.4K $2.0M $148.0K $6.7M
Liabilities
Accounts Payable $972.1K $857.9K $1.0M $1.1M $1.4M $1.4M $310.2K —
Total Current Liabilities $1.7M $3.2M $7.6M $13.9M $10.6M $9.9M $1.7M $6.6M
Long-Term Debt — — — — — — — —
Total Liabilities $1.8M $3.2M $7.7M $13.9M $10.6M $9.9M $1.7M $6.6M
Stockholders' Equity
Retained Earnings $-31.7M $-30.5M $-27.3M $-22.6M $-20.7M $-18.7M $-2.8M $-15.4M
Total Stockholders' Equity $11.8M $3.9M $-6.4M $-11.5M $-9.6M $-8.0M $-1.5M $-774.4K
← Newer Page 1 of 3 Older →